Merck Life Science A/S: Financial statements 2017
CVR: 20830131
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 21,328,958 and a net result of DKK 8,644,278 compared with DKK 6,204,236 the year before. That is an increase of 5.3% compared with the year before. Equity in the 2017 report amounted to DKK 50,351,757. The solvency ratio was 66%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 21,328,958
- Profit/Loss
- DKK 8,644,278
- Equity
- DKK 50,351,757
- Total Assets
- DKK 76,338,722
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 21.3M | 8.6M | 50.4M | 16 |
| 2016 | - | 20.3M | 6.2M | 41.7M | 17 |
| 2015 | - | 34.3M | 7.4M | 35.5M | 17 |
| 2014 | - | 27.5M | 3.9M | 28.1M | - |
| 2013 | - | 26M | 4.2M | 24.2M | - |
Official annual report
Keep an eye on Merck Life Science A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of November 6, 2017, Tiina Marjatta Puhakka has joined the board of directors of Merck Life Science A/S.
As of November 6, 2017, Lutz Schraishuhn has left the board of directors of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2016. Gross profit came to DKK 20,262,564, and the net result was DKK 6,204,236.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.